Answers are grounded in this paper and cite their sources.
We report the case of a 31 years old woman with moderate Intellectual Disability (ID) and Bipolar Affective Disorder who developed Neuroleptic Malignant Syndrome (NMS) after being treated with Olanzapine. Following discontinuation of the Olanzapine, she made a rapid and full recovery.
No takes yet. Share an insight, caveat, or question.
Piacenza et al. (2021) studied this question.